Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
78 Cards in this Set
- Front
- Back
Turner
|
45X0
|
|
Primary amenorrhea with web neck, short stature, low set ears, intact smull, rudimentary ovaries
|
Turner
|
|
Primary amenorrhea with no vagina, no uterus, ovaries ok, breast normal
|
46XX (Rokitansky-Kuster-Hauser syndrome)
|
|
primary amenorrhea with acne, clitoromegaly, hirsutism, no ovaries, no breasts
|
46XY (gonadal dysgenesis)
|
|
primary amenorrhea with atrophic vagina, no cervix, has breasts, no pubic or axillary hair
|
androgen insensitivity syndrome
|
|
primary amenorrhea with anosmia, low LH/FSH
|
Kallman syndrome
|
|
name the primary amenorrhea cases
|
Turner, 46XX, gonadal dysgenesis, androgen insensitivity syndrome, Kallman syndrome
|
|
Hypothalamus-pituitary-gonadal axis immaturity
|
17y/o with amenorrhea, given progesterone and then got her periods; reassure
|
|
patient stopped oral contraceptives, still no menses, pregnancy test negatiuve, LH FSH normal, estrogen challenge with no bleed, diagnosis?
|
Asherman's syndrome or uterine synechiae
|
|
mechanism of amenorrhea in young marathon runner with only a couple of periods the past year
|
excessive exercise inhibits LHRH release
|
|
cushing disease
|
increased ACTH, increased cortisol, increased 17 hydroxy keto steroids
|
|
adrenal carcinoma
|
increased cortisol, increased 17 hydroxy keto steroids decreased ACTH
|
|
congenital adrenal hyperplasia
|
decreased cortisol, increased 17 hydroxy keto steroids increased 17 hydroxy progesterone decreased ACTH
|
|
tests for hirsutism
|
testosterone level, DHEA (17 hydroxy ketosteroids) urine free cortisol
|
|
conditions that can produce gynecomastia
|
cirrhosis, germ cell tumors, Klinefelter's syndrome
|
|
treatment for premature ejaculation
|
SSRIs or sildenafil
|
|
test that differentiates between psychogenic vs organic impotence
|
nocturnal penile tumescence
|
|
differential diagnosis if patient has organic impotence
|
vascular insufficiency, nerves (DM neuropathy), central (HP gonadal axis problem, prolactinoma), hypothyroidism
|
|
patient on tadalafil, given nitrates, blood pressure drops, what to do next?
|
fluids, trendelenburg, phenylephrine (not norepinephrine)
|
|
conditions with increased RAIU
|
Graves, toxic adenoma, MNG
|
|
conditions with decreased RAIU
|
thyroiditis (SAT, postpartum) exogenous T3 T4
|
|
two medications for osteoporosis that is indicated for EVERYTHING (prevention and treatment of postmenopausal osteoporosis, osteo in men; prevention and treatment of CS-induced osteoporosis)
|
risedronate and zoledronate
|
|
when is free testosterone indicated?
|
when SHBG is increased (aging) or decreased (obesity) and total testosterone can be inaccurate
|
|
MOA of sulfonylureas
|
increase release of insulin from B cells (thereby causing weight gain)
|
|
why is repaglinide the drug of choice in renal insufficiency?
|
excreted through bile
|
|
MOA repaglinide / meglitiniides
|
increase release of insulin from B cells (like sulfonylureas)
|
|
how does metformin work?
|
decreases hepatic gluconeogenesis, decreases weight and triglycerides
|
|
mechanism of action of alpha glucosidase inhibitors / acarbose
|
inhibits breakdown of carbohydrates
|
|
mechanism of action of thiazolidinediones or glitazones
|
binds PPAR receptors, increases glucose transport and decreases insulin resistance
|
|
side effects of glitazones
|
lower triglycerides and increases HDL but also increases LDL
|
|
mechanism of action of incretin mimetics (Exanitide or Byetta)
|
decreases hepatic gluconeogenesis
|
|
DPP4 inhibitors
|
sitagliptin / Januvia
|
|
all diabetic treatments cause weight gain except for
|
metformin, incretin, amyulin
|
|
the new diabetic drugs
|
RAID - repaglinide, amylin analogue, incretin mimetics, DPP4 inhibitors
|
|
GLP1 agonists
|
exanatide / incretin mimetics
|
|
PPAR receptor binders
|
glitazones
|
|
when is metformin contraindicated?
|
creatinine more than 1.4 in men or 1.5 in women; advance CHF
|
|
need for iodine during pregnancy / lactation
|
increased by 50% during pregnancy and 100% during lactation
|
|
best test to follow hypothyroidism treatment
|
TSH
|
|
best test to follow hyperthyroidism treatment
|
FT4
|
|
antithyroid drug for pregnant
|
PTU
|
|
treatments used in hyperthyroidism
|
PTU/MMZ; RAI; ASA (for thyroiditis); prednisone / propranolol / hydrocortisone (for storm) plus Surgery
|
|
the only form of hyperthyroidism with increased TSH
|
pituitary adenoma
|
|
what is a normal radioactive iodine uptake?
|
more than 35% is normal; less that 5% is decreased
|
|
findings in RAI uptake scan (4)
|
diffuse for Grave's, focal for toxic nodule; areas of increased and decreased uptake for MNTG and decreased uptake for thyroiditis
|
|
how to differentiate between factitious thyrotoxicosis and thyroiditis?
|
both will have increased FT4 T3 and low TSH plus low RAIU; check thyroglobin levels which will be low in factitious thyrotoxicosis
|
|
these three contidions present the same way: high FT4 T3, low TSH and increased RAIU
|
Grave's, toxic nodule; MNTG (RAIU to differentiate between the three)
|
|
antibodies to differentiate thyroiditis from Grave's
|
anti TSH receptor antibodies (not anti TPO)
|
|
post partum thyroiditis
|
chronic lymphocytic thyroiditis
|
|
half life of levothyroxine
|
7 days
|
|
leading cause of hypothyroidism
|
Hashimoto's
|
|
history of Hashimoto's now with enlarging goiter, what is the diagnosis?
|
B cell lymphoma
|
|
after nuclear explosion, what to give for prophylaxis?
|
potassium iodide
|
|
vitamin D levels
|
less than 20 is deficiency; less than 30 is insufficiency; more than 30 is normal
|
|
treatment of Vitamin D deficiency
|
50K IU per week x 8 weeks then 1-2K/day
|
|
treatment of vitamin D insufficiency
|
1 to 2 thousand per day
|
|
vitamin D supplement
|
600 IU per day if less than 70 years old; 800 IU per day if more than 70 years old
|
|
when to check 25 hydroxy vitamin D 3
|
if considering vitamin d deficiency or intoxication
|
|
when to check 1, 25 hydroxy vitamin D 3
|
sarcoidosis
|
|
action of PTH
|
on kidney - increases calcium absorption and increases phosphate excretion
|
|
action of vitamin D
|
increases intestinal calcium and phosphate absorption
|
|
lab findings in sarcoidosis / vitamin D intoxication
|
increased calcium and phosphate, low PTH
|
|
lab findings in hyperparathyroidism
|
increased PTH, calcium, low phosphate
|
|
lab findings in malignancy / milk alkali syndrome
|
increased calcium, low PTH, low PO4
|
|
MEN 1
|
pituitary, pancreatic (ZES, insulinoma), parathyroid
|
|
MEN 2a
|
parathyroid, pheochromocytoma, medullary thyroid cancer
|
|
MEN 2b
|
pheochromocytoma, medullary thyroid cancer, neuromas
|
|
spectrum of MEN
|
pituitary, pancreatic, parathyroid, pheo, medullary thyroid, neuromas; PETER PAN PARA FEOLI MEDED NEUROMEDED (PETER PAN PARA, PARA FEOLI MEDED, FEOLI MEDED NEUROMEDED)
|
|
how to screen family members of patient diagnosed with medullary thyroid cancer?
|
check calcitonin levels and RET proto oncogene
|
|
in hyperparathyroidism, when is surgery indicated?
|
age less than 50, calcium 11.5 or more; renal stones, symptomatic
|
|
in hyperparathyroid patient refusing surgery, what next?
|
start cinacalcet
|
|
patient with dyspepsia develops hypercalcemia
|
milk alkalil syndrome
|
|
lab findings in pseudohypo parathyroidism
|
high PTH, low calcium, high phosphate
|
|
pathophysiology of pseudo hypo parathyroidism
|
abnormal G protein attached to PTH receptor, PTH binds to receptor but there is no effect
|
|
treatment of osteoporosis
|
bisphosphonates, calcitonin for pain, Vitamin D and calcium, raloxifene, teriparatide
|
|
patient comes in to renew estrogen for osteoporosis treatment
|
stop the estrogen and start bisphosphonates, vitamin D and calcium
|
|
medication that decreases mortality in patients with osteoporosis
|
zoledronate
|
|
most common side effect of zoledronate
|
fever and myalgias
|